Adiponectin and metabolic syndrome in a Tunisian population.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 21912966)

Published in Inflammation on June 01, 2012

Authors

Samir Ben Ali1, Riadh Jemaa, Bouchra Ftouhi, Amani Kallel, Moncef Feki, Hedia Slimene, Naziha Kaabachi

Author Affiliations

1: Research Laboratory LR99ES11, Biochemistry Department, Rabta University Hospital, Jabbari, Tunis 1007, Tunisia. Samir.BenAli@fst.rnu.tn

Articles cited by this

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA (2001) 118.65

Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia (1985) 109.13

Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation (2005) 43.74

The metabolic syndrome. Lancet (2005) 19.47

The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med (2001) 16.51

Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab (2001) 9.53

Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation (2004) 7.77

Plasma adiponectin levels and risk of myocardial infarction in men. JAMA (2004) 7.46

Increasing prevalence of the metabolic syndrome among u.s. Adults. Diabetes Care (2004) 6.68

cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1). Biochem Biophys Res Commun (1996) 5.40

Adipose tissue as an endocrine organ. Mol Cell Endocrinol (2009) 5.20

Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys. Diabetes (2001) 3.61

The metabolic syndrome: prevalence in worldwide populations. Endocrinol Metab Clin North Am (2004) 3.20

Adipokines: molecular links between obesity and atheroslcerosis. Am J Physiol Heart Circ Physiol (2005) 3.15

Prevalence of metabolic syndrome in an urban population: Tehran Lipid and Glucose Study. Diabetes Res Clin Pract (2003) 3.06

Adiponectin promotes macrophage polarization toward an anti-inflammatory phenotype. J Biol Chem (2009) 2.69

Hypoadiponectinemia is an independent risk factor for hypertension. Hypertension (2004) 2.65

Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein. Diabetes (2002) 2.49

Association of serum adiponectin levels with breast cancer risk. Clin Cancer Res (2003) 2.35

Adiponectin replenishment ameliorates obesity-related hypertension. Hypertension (2006) 2.24

Adiponectin as a biomarker of the metabolic syndrome. Circ J (2004) 2.22

Prevalence of metabolic syndrome in an Indian urban population. Int J Cardiol (2004) 2.15

Adiponectin promotes revascularization of ischemic muscle through a cyclooxygenase 2-dependent mechanism. Mol Cell Biol (2009) 1.40

Prevalence of the metabolic syndrome in US populations. Endocrinol Metab Clin North Am (2004) 1.28

Adiponectin: a key player in obesity related disorders. Curr Pharm Des (2010) 1.26

Ageing and plasma adiponectin concentration in apparently healthy males and females. Clin Endocrinol (Oxf) (2005) 1.16

Adiponectin and hypertension. Am J Hypertens (2010) 1.15

High prevalence of metabolic syndrome in Mexico. Arch Med Res (2004) 1.10

An evaluation of the metabolic syndrome in a large multi-ethnic study: the Family Blood Pressure Program. Nutr Metab (Lond) (2005) 1.09

Metabolic syndrome in menopausal transition: Isfahan Healthy Heart Program, a population based study. Diabetol Metab Syndr (2010) 1.09

Adiponectin independently predicts metabolic syndrome in overweight Latino youth. J Clin Endocrinol Metab (2007) 1.06

Prevalence of the metabolic syndrome in the United States National Health and Nutrition Examination Survey 1999-2002 according to different defining criteria. J Clin Hypertens (Greenwich) (2006) 1.05

Relationships between serum adiponectin with metabolic syndrome and components of metabolic syndrome in non-diabetic Koreans: ARIRANG study. Yonsei Med J (2011) 1.00

The metabolic syndrome: prevalence, main characteristics and association with socio-economic status in adults living in Great Tunis. Diabetes Metab (2010) 0.93

Genetics of metabolic syndrome: is there a role for phenomics? Curr Atheroscler Rep (2008) 0.88

Plasma adiponectin distribution in a Mediterranean population and its association with cardiovascular risk factors and metabolic syndrome. Metabolism (2007) 0.85

Metabolic syndrome in the 1982 Pelotas cohort: effect of contemporary lifestyle and socioeconomic status. Arq Bras Endocrinol Metabol (2010) 0.84

Relationship of plasma leptin and adiponectin concentrations with menopausal status in Tunisian women. Cytokine (2011) 0.81

Articles by these authors

Oxidant, antioxidant status and metabolic data in patients with beta-thalassemia. Clin Chim Acta (2003) 1.17

Creatine and creatine deficiency syndromes: biochemical and clinical aspects. Pediatr Neurol (2010) 1.15

Fecal calprotectin is a predictive marker of relapse in Crohn's disease involving the colon: a prospective study. Eur J Gastroenterol Hepatol (2010) 1.06

Incidence of mucopolysaccharidoses in Tunisia. Tunis Med (2009) 0.97

Guanidinoacetate methyltransferase (GAMT) deficiency in two Tunisian siblings: clinical and biochemical features. Clin Lab (2012) 0.95

Aminoacidopathies and organic acidurias in Tunisia: a retrospective survey over 23 years. Tunis Med (2012) 0.94

Association between the -2518G/A polymorphism in the monocyte chemoattractant protein-1 (MCP-1) gene and myocardial infarction in Tunisian patients. Clin Chim Acta (2008) 0.93

Gender-specific effect of Pro12Ala polymorphism in peroxisome proliferator-activated receptor gamma-2 gene on obesity risk and leptin levels in a Tunisian population. Clin Biochem (2009) 0.92

Association of G-2548A LEP polymorphism with plasma leptin levels in Tunisian obese patients. Clin Biochem (2008) 0.90

Molecular, clinical and peripheral neuropathy study of Tunisian patients with ataxia with vitamin E deficiency. Brain (2013) 0.89

Phenylketonuria is still a major cause of mental retardation in Tunisia despite the possibility of treatment. Clin Neurol Neurosurg (2011) 0.88

The paraoxonase L55M and Q192R gene polymorphisms and myocardial infarction in a Tunisian population. Clin Biochem (2010) 0.87

Association of a DNA polymorphism of the apolipoprotein AI-CIII-AIV gene cluster with myocardial infarction in a Tunisian population. Eur J Intern Med (2011) 0.87

G protein beta3 subunit gene C825T and angiotensin converting enzyme gene insertion/deletion polymorphisms in hypertensive Tunisian population. Clin Lab (2013) 0.86

LEPR p.Q223R Polymorphism influences plasma leptin levels and body mass index in Tunisian obese patients. Arch Med Res (2009) 0.85

Prevalence and risk factors of hyperhomocysteinemia in Tunisian patients with Crohn's disease. J Crohns Colitis (2010) 0.84

Thyroid disorders in pregnancy: frequency and association with selected diseases and obstetrical complications in Tunisian women. Clin Biochem (2008) 0.84

Atrial natriuretic peptide and brain natriuretic peptide release in human essential hypertension. Clin Lab (2009) 0.83

Is serum transthyretin a reliable marker of nutritional status in patients with end-stage renal disease? Clin Biochem (2008) 0.83

Plasma homocysteine in schizophrenia: determinants and clinical correlations in Tunisian patients free from antipsychotics. Psychiatry Res (2010) 0.83

Association between the -2518G/A polymorphism in the monocyte chemoattractant protein-1 (MCP-1) gene and hypertension in Tunisian patients. Clin Biochem (2008) 0.82

Changes in membrane fatty acid composition of Pseudomonas aeruginosa in response to UV-C radiations. Curr Microbiol (2013) 0.82

Status of vitamins A and E in schoolchildren in the centre west of Tunisia: a population-based study. Public Health Nutr (2010) 0.82

Nutritional practice effectiveness to achieve adequate plasma vitamin A, E and D during the early postnatal life in Tunisian very low birth weight infants. J Matern Fetal Neonatal Med (2014) 0.82

Polymorphisms of the NOS3 gene and risk of myocardial infarction in the Tunisian population. Cytokine (2013) 0.81

[Erythrocyte abnormalities in thyroid dysfunction]. Tunis Med (2010) 0.81

Hyperhomocysteinemia is associated with deep venous thrombosis of the lower extremities in Tunisian patients. Clin Biochem (2006) 0.81

Abnormal expression of chemokine receptors in Behçet's disease: relationship to intracellular Th1/Th2 cytokines and to clinical manifestations. J Autoimmun (2004) 0.81

Relationship of plasma leptin and adiponectin concentrations with menopausal status in Tunisian women. Cytokine (2011) 0.81

Tc1/Tc2 ratio in the inflammatory process in patients with Behçet's disease. Mediators Inflamm (2004) 0.81

Metabolic Syndrome, Independent Predictor for Coronary Artery Disease. Clin Lab (2015) 0.80

Association between endothelial nitric oxide gene intron 4a4b VNTR polymorphism and plasma homocysteine concentrations in Tunisian male patients with myocardial infarction. Nutr Res (2012) 0.80

Association between the 2756A> G variant in the gene encoding methionine synthase and myocardial infarction in Tunisian patients. Clin Chem Lab Med (2008) 0.80

HLA class II alleles susceptibility markers of type 1 diabetes fail to specify phenotypes of ketosis-prone diabetes in adult Tunisian patients. Exp Diabetes Res (2011) 0.80

High frequency of W1327X mutation in glycogen storage disease type III patients from central Tunisia. Ann Biol Clin (Paris) (2012) 0.79

Serum lipid level in Tunisian patients with psoriasis. Clin Lab (2014) 0.79

Hemolytic anemia and metabolic acidosis: think about glutathione synthetase deficiency. Fetal Pediatr Pathol (2014) 0.79

[Osteoporosis and inflammatory bowel disease: prevalence and risk factors in Tunisian patients]. Gastroenterol Clin Biol (2003) 0.79

Screening of three Mediterranean phenylketonuria mutations in Tunisian families. J Genet (2012) 0.79

Association of rs2781666 G/T polymorphism of arginase I gene with myocardial infarction in Tunisian male population. Clin Biochem (2009) 0.79

C(-260)T polymorphism in the promoter of CD 14 gene is not associated with myocardial infarction in the Tunisian population. Exp Mol Pathol (2011) 0.78

Peripheral blood levels of matrix and inflammatory mediators are elevated in Tunisian patients with acute coronary syndromes. Clin Lab (2013) 0.78

Molecular and biochemical characterization of a novel intronic single point mutation in a Tunisian family with glycogen storage disease type III. Mol Biol Rep (2013) 0.78

Artemisia herba-alba Asso (Asteraceae) has equivalent effects to green and black tea decoctions on antioxidant processes and some metabolic parameters in rats. Ann Nutr Metab (2007) 0.78

GC/MS determination of guanidinoacetate and creatine in urine: A routine method for creatine deficiency syndrome diagnosis. Clin Biochem (2010) 0.77

C677t polymorphism of MTHFR and G80A polymorphism of RFC genes and their relation with homocysteine levels in obese Tunisian children. Tunis Med (2011) 0.77

Association of a 27-bp repeat polymorphism in intron 4 of endothelial constitutive nitric oxide synthase gene with hypertension in a Tunisian population. Clin Biochem (2008) 0.77